Verani et al. - Google Patents
and Annalaura CarducciVerani et al.
View PDF- Document ID
- 3129291074382981158
- Author
- Verani M
- Federigi I
- Lauretani G
- Muzio S
- Publication venue
- Advances in Microbiology, Infectious Diseases and Public Health
External Links
Snippet
The availability of virucidal compounds to reduce the impact of respiratory viruses is a relevant topic for public health, especially during the recent coronavirus disease (COVID-19) pandemic. Antimicrobial properties of Xibornol are known since the 1970s, but its activity on …
- 229960001643 xibornol 0 abstract description 68
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Droebner et al. | CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice | |
| Shi et al. | Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo | |
| Wood et al. | The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses | |
| Darnell et al. | Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV | |
| Zhong et al. | Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo | |
| Oxford et al. | A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV | |
| US20160166624A1 (en) | Anti-viral compositions | |
| Boltz et al. | Antiviral activity of enisamium against influenza viruses in differentiated normal human bronchial epithelial cells | |
| US20130236580A1 (en) | Methods of Treating or Preventing Influenza, Infantile Acute Respiratory Infectious Disease, and Acquired Immune Deficiency Syndrome | |
| Verani et al. | and Human Respiratory Syncytial Virus | |
| Stephen et al. | Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes | |
| Verani et al. | In Vitro Potential Virucidal Effect Evaluation of Xibornol on Human Adenovirus Type 5, Human Rhinovirus Type 13, Human Coronavirus 229E, Human Parainfluenza Virus Type 1, and Human Respiratory Syncytial Virus | |
| CN105287539B (en) | The new opplication of Corydaline | |
| CN106038536A (en) | Application of columbianedin to medicine preparation | |
| JP2023533041A (en) | Use of Taurolidine against viruses | |
| Alymova et al. | Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice–further evaluation | |
| Verani et al. | and Annalaura Carducci | |
| US20230151302A1 (en) | Cationic surfactants, in particular ethyl lauroyl arginate LAE, for treating or preventing infections and contaminations with Coronavirus | |
| CN104906117B (en) | Application of the 1,6- diphosphofructoses in the drug of prevention infection of coated virus and virus inactivator is prepared | |
| RU2118163C1 (en) | Drug for treatment of patients with viral disease | |
| CN103705506B (en) | Application of enilconazole in preparing drug for treating or preventing influenza virus infections | |
| CN103705497B (en) | Application of liothyronine in preparation of medicine for treatment or prevention of influenza virus infection | |
| Shigeta | Approaches to antiviral chemotherapy for acute respiratory infections | |
| Ishida | Zinc (Ⅱ) Immune Virucidal Activities for 2019-nCoV Prevention and COVID-19 Respiratory Ailment and Pneumonia | |
| JP2022055977A (en) | Inhibitor for new coronavirus growth |